Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells

International Journal of Cancer

Volumn 130, Issue 7, 2012, Pages 1544-1557

  Micutkova, Lucia ^a   Hermann, Martin ^b   Offterdinger, Martin ^b   Hess, Michael W ^b   Matscheski, Andrea ^a   Pircher, Haymo ^a   Mück, Christoph ^a   Ebner, Hannes Leonhard ^b   Laich, Andreas ^a   Ferrando May, Elisa ^c   Zwerschke, Werner ^a   Huber, Lukas A ^b   Jansen Dürr, Pidder ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

endocytosis; IGFBP 3; importin; nuclear transport; trafficking

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL ASSAY; CELL FRACTIONATION; CELL LEVEL; CELL NUCLEUS MEMBRANE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR DOCKING; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

BONE NEOPLASMS; CELL FRACTIONATION; CELL NUCLEUS; CYTOPLASM; ENDOCYTOSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 84856326484     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26149     Document Type: Article

References (47)

1. Valentinis B, Baserga R,. IGF-I receptor signalling in transformation and differentiation. Mol Pathol 2001; 54: 133-7. (Pubitemid 32539602)
2. Jones JI, Clemmons DR,. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
3. Kurmasheva RT, Houghton PJ,. IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta 2006; 1766: 1-22. (Pubitemid 44175635)
4. Firth SM, Baxter RC,. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 824-54. (Pubitemid 35454590)
5. Yamada PM, Lee KW,. Perspectives in Mammalian IGFBP-3 Biology: Local vs. Systemic Action. Am J Physiol Cell Physiol 2009; 296: C954-76.
6. Buckbinder L, Talbott R, Velascomiguel S, Takenaka I, Faha B, Seizinger BR, Kley N,. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377: 646-49.
7. Rajah R, Valentinis B, Cohen P,. Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997; 272: 12181-88. (Pubitemid 27202802)
8. Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Durr P, Zwerschke W,. Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 2000; 20: 6483-95. (Pubitemid 30650235)
9. Santer FR, Moser B, Spoden GA, Jansen-Durr P, Zwerschke W,. Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor binding protein-3 by inducing its ubiquitin/proteasome-dependent degradation. Carcinogenesis 2007; 28: 2511-20. (Pubitemid 350238953)
10. Santer FR, Bacher N, Moser B, Morandell D, Ressler S, Firth SM, Spoden GA, Sergi C, Baxter RC, Jansen-Durr P, Zwerschke W,. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res 2006; 66: 3024-33.
11. Hampel OZ, Kattan MW, Yang G, Haidacher SJ, Saleh GY, Thompson TC, Wheeler TM, Marcelli M,. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study. J Urol 1998; 159: 2220-5. (Pubitemid 29190810)
12. Hong J, Zhang G, Dong F, Rechler MM,. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002; 277: 10489-97. (Pubitemid 34968171)
13. Silha JV, Sheppard PC, Mishra S, Gui Y, Schwartz J, Dodd JG, Murphy LJ,. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology 2006; 147: 2112-21.
14. Cohen P,. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 2006; 147: 2109-11.
15. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC,. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J Biol Chem 2000; 275: 23462-70. (Pubitemid 30624626)
16. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K,. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 1997; 138: 1767-70. (Pubitemid 27137133)
17. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P,. Direct functional interactions between insulin-like growth factor- binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000; 275: 33607-13.
18. Cobb LJ, Mehta H, Cohen P,. Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation. Mol Endocrinol 2009; 23: 1624-33.
19. Schedlich LJ, Young TF, Firth SM, Baxter RC,. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998; 273: 18347-52. (Pubitemid 28334760)
20. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P,. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 2004; 279: 469-76. (Pubitemid 38044848)
21. Pircher H, Matscheski A, Laich A, Hermann M, Moser B, Viertler HP, Micutkova L, Lindner H, Sarg B, Zwerschke W, Jansen-Durr P,. A new method for the purification of bioactive insulin-like growth factor-binding protein-3. Protein Expr Purif 2010; 71: 160-7.
22. Cao H, Thompson HM, Krueger EW, McNiven MA,. Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. J Cell Sci 2000; 113: 1993-2002. (Pubitemid 30386503)
23. Hess MW, Muller M, Debbage PL, Vetterlein M, Pavelka M,. Cryopreparation provides new insight into the effects of brefeldin A on the structure of the HepG2 Golgi apparatus. J Struct Biol 2000; 130: 63-72. (Pubitemid 30470798)
24. Robinson JM, Karnovsky MJ,. Rapid-freezing cytochemistry: preservation of tubular lysosomes and enzyme activity. J Histochem Cytochem 1991; 39: 787-92.
25. van Donselaar E, Posthuma G, Zeuschner D, Humbel BM, Slot JW,. Immunogold labeling of cryosections from high-pressure frozen cells. Traffic 2007; 8: 471-85. (Pubitemid 46638560)
26. Shah N, Zhang S, Harada S, Smith RM, Jarett L,. Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin. Endocrinology 1995; 136: 2825-35.
27. Jerome L, Alami N, Belanger S, Page V, Yu Q, Paterson J, Shiry L, Pegram M, Leyland-Jones B,. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2- overexpressing breast tumors and potentiates herceptin activity in vivo. Cancer Res 2006; 66: 7245-52. (Pubitemid 44197705)
28. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, Cohen P,. Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 2001; 86: 1806-13. (Pubitemid 32374942)
29. Hinrichsen L, Harborth J, Andrees L, Weber K, Ungewickell EJ,. Effect of clathrin heavy chain- and alpha-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells. J Biol Chem 2003; 278: 45160-70. (Pubitemid 37432649)
30. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293: 2449-52. (Pubitemid 32917325)
31. Dharmawardhane S, Schurmann A, Sells MA, Chernoff J, Schmid SL, Bokoch GM,. Regulation of macropinocytosis by p21-activated kinase-1. Mol Biol Cell 2000; 11: 3341-52.
32. Ungewickell EJ, Hinrichsen L,. Endocytosis: clathrin-mediated membrane budding. Curr Opin Cell Biol 2007; 19: 417-25. (Pubitemid 47271962)
33. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY,. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 2004; 22: 1567-72. (Pubitemid 40039460)
34. Rabut G, Doye V, Ellenberg J,. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol 2004; 6: 1114-21. (Pubitemid 39468013)
35. Wagstaff KM, Jans DA,. Importins and beyond: non-conventional nuclear transport mechanisms. Traffic 2009; 10: 1188-98.
36. Kutay U, Izaurralde E, Bischoff FR, Mattaj IW, Gorlich D,. Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex. EMBO J 1997; 16: 1153-63. (Pubitemid 27136082)
37. Jurgeit A, Berlato C, Obrist P, Ploner C, Massoner P, Schmölzer J, Haffner MC, Klocker H, Huber LA, Geley S, Doppler W,. Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic 2007; 8: 1815-28. (Pubitemid 350066691)
38. Butt AJ, Dickson KA, McDougall F, Baxter RC,. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 2003; 278: 29676-85. (Pubitemid 36962353)
39. Doherty GJ, McMahon HT,. Mechanisms of endocytosis. Annu Rev Biochem 2009; 78: 857-902.
40. Leal SM, Liu Q, Huang SS, Huang JS,. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 1997; 272: 20572-6. (Pubitemid 27355615)
41. Carpenter G, Liao HJ,. Trafficking of receptor tyrosine kinases to the nucleus. Exp Cell Res 2009; 315: 1556-66.
42. Wang YN, Yamaguchi H, Huo L, Du Y, Lee HJ, Lee HH, Wang H, Hsu JM, Hung MC,. The translocon SEC61{beta} localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. J Biol Chem 2010; 285: 38720-9.
43. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R,. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 2002; 277: 32078-85. (Pubitemid 34969019)
44. Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R,. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol 2003; 17: 472-86. (Pubitemid 36315640)
45. Sehat B, Tofigh A, Lin Y, Trocmé E, Liljedahl U, Lagergren J, Larsson O,. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 2010; 3: ra10.
46. Panetta D, Biedi C, Repetto S, Cordera R, Maggi D,. IGF-I regulates caveolin 1 and IRS1 interaction in caveolae. Biochem Biophys Res Commun 2004; 316: 240-3. (Pubitemid 38299151)
47. Chen J, Capozza F, Wu A, Deangelis T, Sun H, Lisanti M, Baserga R,. Regulation of insulin receptor substrate-1 expression levels by caveolin-1. J Cell Physiol 2008; 217: 281-9.